Johnny Mahlangu to Genetic Therapy
This is a "connection" page, showing publications Johnny Mahlangu has written about Genetic Therapy.
Connection Strength
3,000
-
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A. J Thromb Haemost. 2024 Jul; 22(7):1880-1893.
Score: 0,884
-
The translational gap for gene therapies in low- and middle-income countries. Sci Transl Med. 2024 May 08; 16(746):eadn1902.
Score: 0,222
-
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy. J Thromb Haemost. 2024 May; 22(5):1510-1515.
Score: 0,217
-
Implementation of a gene therapy education initiative by the ASGCT and Muhimbili University of Health and Allied Sciences. Mol Ther. 2023 09 06; 31(9):2561-2565.
Score: 0,211
-
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India. Mol Ther. 2022 Jun 01; 30(6):2122-2129.
Score: 0,192
-
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A. N Engl J Med. 2022 03 17; 386(11):1013-1025.
Score: 0,191
-
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing. Lancet. 2021 02 13; 397(10274):630-640.
Score: 0,177
-
The evolving landscape of gene therapy for congenital haemophilia: An unprecedented, problematic but promising opportunity for worldwide clinical studies. Blood Rev. 2021 03; 46:100737.
Score: 0,171
-
World Federation of Hemophilia Gene Therapy Registry. Haemophilia. 2020 Jul; 26(4):563-564.
Score: 0,169
-
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table. Haemophilia. 2020 May; 26(3):443-449.
Score: 0,167
-
Gene and cell therapy in South Africa: Current status and future prospects. S Afr Med J. 2019 Sep 10; 109(8b):12-16.
Score: 0,161
-
Emerging therapies for haemophilia - Global perspective. Haemophilia. 2018 May; 24 Suppl 6:15-21.
Score: 0,146
-
Haemophilia gene therapy-Update on new country initiatives. Haemophilia. 2022 May; 28 Suppl 4:61-67.
Score: 0,048
-
Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 11; 18(11):3074-3077.
Score: 0,044